Skip to content

PP&E (Net) at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$7.66B+6.2%
Pfizer logo
PfizerPFE
$19.4B+5.8%
Immunome logo
ImmunomeIMNM
$17.08M+55.9%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$38M-17.4%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$177K
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
$8.63M-2.7%

Other financials

Income statement

See full
Revenue$83.2M+2,599%
Gross profit$9.8M+1,340%
Operating income$3.9M+107%
Net income$5.4M+110%
EPS (diluted)$0.01+106%

Balance sheet

See full
Cash & equivalents$125.4M+161%
Total debt$57.2M+401%
Total equity$319.6M-23.8%
Total assets$610.2M+23.9%

Cash flow

See full
Operating cash flow$5.1M+112%
CapEx$48.0K-33.3%
Free cash flow$5.0M+112%

Valuation

See full
Market cap$2.1B+150%
Enterprise value$2.03B+154%
P/S14.7×-62.0×

Profitability

See full
Gross margin54.3%+39.5pp
Operating margin-105%-52.0pp
Net margin-102.1%-50.6pp
FCF margin-93.5%-45.2pp

Returns & leverage

See full
Return on equity-39.5%-15.8pp
Debt / equity0.2×+0.2×
Current ratio7.4×-1.6×

Where this comes from

Reported directly by Nuvation Bio in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Nuvation Bio’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvation Bio's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nuvation Bio's PP&E (net)?
Nuvation Bio (NUVB) reported PP&E (net) of $535K in Q1 2026.
How has Nuvation Bio's PP&E (net) changed year-over-year?
Nuvation Bio's PP&E (net) decreased by 4.8% year-over-year, from $562K to $535K.
What is the long-term trend for Nuvation Bio's PP&E (net)?
Over 5 years (2020 to 2025), Nuvation Bio's PP&E (net) has grown at a -3.9% compound annual growth rate (CAGR), from $688K to $564K.
What does PP&E (net) mean?
Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.